Cardiopulmonary Stress Testing Systems Market Size & Share, by Product (Cardiopulmonary exercise testing (CPET) systems, Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors, Single Photon Emission Computed Tomography (SPECT)); Application (Oxygen Uptake, Minute Ventilation, Anaerobic Threshold); End-User (Hospitals, Specialty Clinics/Cardiology Clinics, Ambulatory Surgical Centers, Diagnostic Centers)-Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5834
  • Published Date: Mar 08, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Cardiopulmonary Stress Testing Systems Market size is expected to reach USD 15 Billion by the end of 2036, growing at a CAGR of 5% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of cardiopulmonary stress testing systems was USD 7 Billion. Rapid increase in frequency of cardiovascular diseases is fueling the expansion of the market. According to WHO, around 17.9 million people die worldwide due to cardiovascular diseases. Moreover, four out of five deaths are caused due to heart attacks and strokes, and one third occur prematurely in population under 70 years of age.

People are changing their lifestyles and adopting new habits for improving health conditions including cutting down the use of tobacco, reducing the consumption of salt in the diet, eating more fruit and vegetables, regular physical activity, and avoiding alcohol.


Cardiopulmonary Stress Testing Software Market
Get more information on this report: Request Free Sample PDF

Cardiopulmonary Stress Testing Systems Market: Growth Drivers and Challenges

Growth Drivers

  • Increase in Elderly Population: The building up of multiple kinds of molecular and cellular damage over time causes aging. This leads to progressive loss in physical and mental health conditions collectively referred to as geriatric syndromes which is another sign of older age. These people are more prone to osteoarthritis, hearing loss, cataracts, diabetes, depression, dementia, and heart-related diseases. Maintaining a healthy lifestyle including eating a balanced diet and engaging in regular physical activity contributes to reducing the risk of non-communicable diseases. According to WHO in 2020, the ratio of a number of people aged 60 years and older exceeded children younger than 5 years.
  • Technological Advancements for Improved Diagnostics: Introduction and integration of diagnostic procedures for heart disorders such as arrhythmia & valve imbalance is fueling the growth of cardiopulmonary stress testing systems. These developments include manufacturing techniques and digital technology to improve the quality of testing services. The widespread increase in heart disease has led to a growth in demand for cardiovascular devices. Moreover, providers are currently concentrating on virtual platforms in order to facilitate quick and accurate diagnosis without location being a barrier. Medical sector is having an enormous positive impact from digital health services and mobile health applications. For instance, a report published by Medical Device and Diagnostic Industry in 2022, FDA has given approval for most convenient and slimmest ECG device created by KardiaMobile Card. It is designed to fit into wallet and deliver a medical grade single-Lead ECG in 30 seconds.

Challenges

  • High Cost of Testing Solutions: The cost of software-based stress testing solutions is quite high which can delay the Cardiopulmonary stress testing systems sector growth over the coming years. For large-scale projects cost required for the development and installation of testing system solutions is huge which can act as a barrier resulting in preventing development in the medical sector.
  • Combating technologies such as fossil fuels and nuclear energy can create a threat to the adoption of cardiopulmonary stress testing systems solutions mainly in the regions where these technologies are well developed.
  • Any disturbance in the supply chain including shortage of materials can influence the availability and cost of testing solutions.

Cardiopulmonary Stress Testing Systems Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

~5%

Base Year Market Size (2023)

~ USD 7 Billion

Forecast Year Market Size (2036)

~ USD 15 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Cardiopulmonary Stress Testing Systems Segmentation

Product Type (Cardiopulmonary exercise testing (CPET) systems, Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors)

The cardiopulmonary exercise testing (CPET) systems segment is predicted to account for 35% share of the global cardiopulmonary stress testing systems market by 2036. The segment growth can be attributed to the precision and quick operation while diagnosis. Moreover, cost-effectiveness and usage in different places have increased the preference between doctors and patients. CPET system provides recognizable and complimentary evaluation by providing a more accurate and reliable measurement of a patient’s functional capacity. For instance, a report was published in 2023 which states that CPET is a safe process having the risk of death for patients between 2 and 5 per 100,000 exercise tests performed.

End-User (Hospitals, Specialty Clinics/Cardiology Clinics, Ambulatory Surgical Centers, Diagnostic Centers)

The hospital segment is predicted to account for 37% share of the global cardiopulmonary stress testing systems market by 2036. The segment growth can be attributed to the government policies adopted to increase admissions in hospitals for cardiovascular diseases. People prefer hospital-based treatments as they provide early diagnosis and stress testing procedures are widely adopted at these facilities. Hospitals provide top-quality medical care to patients without any complications for existing patients.

Our in-depth analysis of the global market includes the following segments:

          Product

  • Cardiopulmonary exercise testing (CPET) systems
  •  Stress ECG
  • Pulse Oximeters
  • Stress Blood Pressure Monitors

          Application

  • Oxygen Uptake
  • Minute Ventilation
  • Anaerobic Threshold

          End-User

  • Hospitals
  • Specialty Clinics/Cardiology Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Cardiopulmonary Stress Testing Systems Industry - Regional Synopsis

North America Market Forecast

The cardiopulmonary stress testing systems market in North America is anticipated to hold the largest with a share of about 34% by the end of 2036. The market growth in the region is also expected on account of a rise in hospital admissions, the deployment of novel products by healthcare facilities, efficiency in the early detection of cardiovascular diseases and increase in the number of cardiac specialty centers. Moreover, the latest cardiac care services and huge investment by the government in the healthcare sector are leading to regional growth. Skilled doctors are available on a large scale for treating patients as the rate of heart disease is very high in the region. Various private and government organizations are taking initiatives including program launches and funding for raising awareness among people. For instance, a report published by the American Heart Association in 2020 states that around 28 million non-cardiac surgical procedures are performed in the United States every year. The introduction of cardiopulmonary stress testing systems can help fight heart diseases and reduce mortality rates.

European Market Analysis

The Europe cardiopulmonary stress testing systems market is estimated to be the second largest, registering a share of about 23% by the end of 2036. The market’s expansion can be attributed majorly to the increasing demand for cardiovascular disease monitoring, diagnostic machines and rising awareness of stress testing are the factors fueling the regional growth. During the pandemic, some European Union member states were under high pressure as the number of patients increased which resulted in a shortage of staff in hospitals and daycare centers. The patients were highly infected and were under quarantine which hindered easy access to medical services due to travel restrictions. According to the European Union, around 37,200 heart bypass surgeries were conducted in Germany in 2021 and 17,400 were conducted in France. Moreover, the rise in adoption and invasion of the latest testing systems at hospitals and institutions that instruct doctors and nurses in monitoring patients’ health accelerate the development of testing systems.

Research Nester
Cardiopulmonary Stress Testing Software Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Cardiopulmonary Stress Testing Systems Landscape

top-features-companies
    • Schiller
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Spacelabs Healthcare
    • Siemens Heathineers
    • Koninklijke Philips NV
    • Cosmed
    • MGC Diagnostics Corporation
    • Halma plc
    • Nonin Medical Inc.
    • Hill-Rom
    • Vyaire Medical, Inc.

In-the-news

In The News

  • Halma, has inaugurated a new facility in China in order to support and promote the latest innovation and growth in the Asia Pacific region. There are 15 operating in the environmental & healthcare sector which have relocated to Shanghai in 11,000 square meters area. Halma entered China in 2006 and now it has given employment to 800 people, working in 40 operating companies. Furthermore, 6% of revenue is obtained from China along with 15% of Group revenue from the wider APAC region.
  • Vyaire, started a voluntary field correction for certain bellavista ventilators. The ventilators are installed with specific software versions and configuration combinations which can cease ventilation and generate alarms in case of technical failure. The software version already installed has been notified by Vyaire to urgently disable the HL7 data communication as the risk of unintentional ceasing of ventilation was reported.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5834
  • Published Date: Mar 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rapid increase in the frequency of cardiovascular diseases and initiatives taken by government organizations to create awareness among people are the major factors driving the growth of cardiopulmonary stress testing systems market.

The market size of cardiopulmonary stress testing systems market is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2024-2036.

The major players in the market are Schiller, Spacelabs Healthcare, Siemens Heathineers, Koninklijke Philips NV, Cosmed, MGC Diagnostics Corporation, Halma plc, Nonin Medical Inc., Hill-Rom, Vyaire Medical, Inc. and others.

The cardiopulmonary exercise testing (CPET) systems segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Cardiopulmonary Stress Testing System Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying